ストックスクリーナーアプリを入手
0.731
2.61%
-0.0196
前日終値:
$0.7506
開ける：
$0.82
24時間の取引高:
17,346
Relative Volume:
0.12
時価総額：
$32.72M
収益：
$80.28M
当期純損益:
$-38.83M
株価収益率:
-0.8788
EPS:
-0.8318
ネットキャッシュフロー:
$-28.67M
1週間 パフォーマンス:
-13.70%
1か月 パフォーマンス:
-14.91%
6か月 パフォーマンス:
-28.33%
1年 パフォーマンス:
-63.08%
1日の値動き範囲:
$0.7303
$0.82
1週間の範囲:
$0.7201
$0.905
52週間の値動き範囲:
$0.5011
$2.1859
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.731 | 33.60M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
100.68 | 172.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
319.87 | 126.97B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.20 | 106.96B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.03 | 66.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 50.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Tela Bio Inc (TELA) 最新ニュース
Form 4 Tela Bio Inc For: 17 July By Investing.com - Investing.com Canada
TELA Bio (TELA) awards director 6,227 fully vested compensation shares - Stock Titan
TELA Bio advances hernia repair through innovation in medical science - Traders Union
TELA Stock Price, Quote & Chart - ChartMill
TELATELA Bio Inc Dividends - Finviz
TELA Bio Inc. (TELA) Shows Modest Uptick as Stock Tests Key ResistanceVolume Weighted Price - DonanımHaber
TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA) - TradingView
TELA Bio, Inc. Actuals & Estimates (BOATS:TELA) - TradingView
TELA Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to earnings forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to sales forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
TELA Bio Inc (TELA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TELA Bio Inc (TELA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TELA Bio Inc (TELA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TELA Bio Inc (TELA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TELA Bio Inc (TELA) Institutional Confidence - TradingKey
TELA Bio Inc (TELA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TELA Bio Inc. (TELA) Slides 5.7% as Shares Approach Critical Support at $0.82Volatility Breakout Picks - newsline.com
TELA Bio (TELA) grants director new RSUs and stock options - Stock Titan
TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options - Stock Titan
TELA Bio (NASDAQ: TELA) grants director new stock and options - Stock Titan
Joseph H. Capper joins TELA Bio (TELA) board and files initial insider report - Stock Titan
TELA Bio (TELA) director awarded 11,675 shares and options for 17,335 - Stock Titan
Director Guido J. Neels files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
TELA Bio : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership - Stock Titan
TELA Bio (TELA) director Paul Thomas receives RSU and option grants - Stock Titan
Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Shareholders Expand Equity Incentive Plan Authorization - TipRanks
TELA Bio (NASDAQ: TELA) OKs 3.5M-share incentive plan boost - Stock Titan
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesRevenue Recognition Risk - newsline.com
EW Healthcare Partners Fund 2-UGP Secures Board Seat at TELA Bio with 17.23% Stake - TradingView
EW Healthcare funds report 7.7M TELA Bio (TELA) shares and board seat - Stock Titan
TELA Bio Inc Annual Shareholders Meeting Transcript - GuruFocus
TELA Q1 2026 Earnings: EPS Miss Sends Stock Slightly LowerRevenue Inflection Point - newsline.com
TELA Bio Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesSurprise Factor Analysis - DonanımHaber
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio | 8-K: Current report - Moomoo
TELA Bio Expands Europe Sales as U.S. Growth Slows - MyChesCo
TELA Bio Inc. (TELA) Edges Lower, Tests Key Support After 2.7% DeclineUser Trade Ideas - Newser
Tela Bio Eyes Second-Half Ramp After Mixed Quarter - TipRanks
TELA Bio (TELA) Q1 2026 Results Miss Estimates — EPS $-0.21 vs $-0.19Retail Earnings Report - Newser
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
2.81%
大文字化:
|
ボリューム (24 時間):